Kristin Means
Family · Austin, TXNPI 1417508490
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 322 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 38.5% of the total. Among family clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 322 payments — averaging $17.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$770
- QOL Medical, LLC$338
- Johnson & Johnson$328
- Nestle Healthcare Nutrition Inc.$270
- Bristol Myers Squibb$217
- plus $2K from 18 others
What the payments were for
- Food & beverage$5,589100%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 103 | $2,156 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 64 | $770 |
| QOL Medical, LLC | 21 | $338 |
| Johnson & Johnson(3 entities) | 20 | $328 |
| Nestle Healthcare Nutrition Inc. | 14 | $270 |
| Bristol Myers Squibb | 18 | $217 |
| Intercept Pharmaceuticals, Inc. | 13 | $198 |
| Evoke Pharma, Inc. | 7 | $178 |
| Regeneron Healthcare Solutions, Inc. | 7 | $160 |
| Daiichi Sankyo Inc. | 7 | $131 |
| Ardelyx, Inc. | 6 | $117 |
| Ironwood Pharmaceuticals, Inc | 6 | $106 |
| Pfizer | 6 | $102 |
| Ferring Pharmaceuticals Inc. | 6 | $82 |
| Pharmacosmos Therapeutics Inc. | 4 | $78 |
| Redhill Biopharma Inc. | 4 | $77 |
| Organon | 3 | $55 |
| AMAG Pharmaceuticals, Inc. | 3 | $49 |
| Amgen | 2 | $40 |
| Sanofi | 2 | $39 |
| Braintree Laboratories, Inc. | 2 | $35 |
| Gilead | 2 | $31 |
| Shield Therapeutics Inc | 1 | $24 |
| Merck | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,596 in reported general payments places this provider in the 90th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 43 | $619 |
| Pantoprazole Sodium | 43 | $439 |
| Famotidine | 13 | $216 |
Paid to pharmacies, not to this prescriber.
Other family in Austin
- Monique MulvanyAustin$142K
- Barry HughesAustin$51K
- Eric PerezAustin$42K
- Chelsea CrillyAustin$36K
- Alexandra RossiAustin$35K
- Angelina DetmersAustin$33K
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.